212 related articles for article (PubMed ID: 34671029)
1. Tumor-suppressive function of EZH2 is through inhibiting glutaminase.
Liu Y; Tu CE; Guo X; Wu C; Gu C; Lai Q; Fang Y; Huang J; Wang Z; Li A; Liu S
Cell Death Dis; 2021 Oct; 12(11):975. PubMed ID: 34671029
[TBL] [Abstract][Full Text] [Related]
2. Enhancer of zeste homolog 2 (EZH2)-dependent sirtuin-3 determines sensitivity to glucose starvation in radioresistant head and neck cancer cells.
Chang HW; Park JJ; Lee WH; Kim SH; Lee JC; Nam HY; Kim MR; Han MW; Lee YS; Kim SY; Kim SW
Cell Signal; 2024 Mar; 115():111029. PubMed ID: 38163576
[TBL] [Abstract][Full Text] [Related]
3. Symphony of epigenetic and metabolic regulation-interaction between the histone methyltransferase EZH2 and metabolism of tumor.
Zhang T; Gong Y; Meng H; Li C; Xue L
Clin Epigenetics; 2020 May; 12(1):72. PubMed ID: 32448308
[TBL] [Abstract][Full Text] [Related]
4. Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice.
Boysen G; Jamshidi-Parsian A; Davis MA; Siegel ER; Simecka CM; Kore RA; Dings RPM; Griffin RJ
Int J Radiat Biol; 2019 Apr; 95(4):436-442. PubMed ID: 30557074
[TBL] [Abstract][Full Text] [Related]
5. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
6. Hotair mediates tumorigenesis through recruiting EZH2 in colorectal cancer.
Huang KB; Zhang SP; Zhu YJ; Guo CH; Yang M; Liu J; Xia LG; Zhang JF
J Cell Biochem; 2019 Apr; 120(4):6071-6077. PubMed ID: 30362162
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.
Shen YA; Hong J; Asaka R; Asaka S; Hsu FC; Suryo Rahmanto Y; Jung JG; Chen YW; Yen TT; Tomaszewski A; Zhang C; Attarwala N; DeMarzo AM; Davidson B; Chuang CM; Chen X; Gaillard S; Le A; Shih IM; Wang TL
Cancer Res; 2020 Oct; 80(20):4514-4526. PubMed ID: 32859605
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7.
Di W; Weinan X; Xin L; Zhiwei Y; Xinyue G; Jinxue T; Mingqi L
Cell Death Dis; 2019 Jul; 10(7):514. PubMed ID: 31273190
[TBL] [Abstract][Full Text] [Related]
9. Enhancer of zeste homolog 2 modulates oxidative stress-mediated pyroptosis in vitro and in a mouse kidney ischemia-reperfusion injury model.
Liu H; Chen Z; Weng X; Chen H; Du Y; Diao C; Liu X; Wang L
FASEB J; 2020 Jan; 34(1):835-852. PubMed ID: 31914694
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-506-3p inhibits colorectal cancer cell proliferation through targeting enhancer of zeste homologue 2.
Ai L; Luo X; Yan X; Jiang S
Bioengineered; 2021 Dec; 12(1):4044-4053. PubMed ID: 34288823
[TBL] [Abstract][Full Text] [Related]
11. The carcinogenic complex lncRNA DUXAP8/EZH2/LSD1 accelerates the proliferation, migration and invasion of colorectal cancer.
Gong A; Huang Z; Ge H; Cai Y; Yang C
J BUON; 2019; 24(5):1830-1836. PubMed ID: 31786844
[TBL] [Abstract][Full Text] [Related]
12. Hsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer.
Yong W; Zhuoqi X; Baocheng W; Dongsheng Z; Chuan Z; Yueming S
Biomed Pharmacother; 2018 Jun; 102():1188-1194. PubMed ID: 29710537
[TBL] [Abstract][Full Text] [Related]
13. The oncogenic role of LncRNA FAM83C-AS1 in colorectal cancer development by epigenetically inhibits SEMA3F via stabilizing EZH2.
Xue W; Wang F; Han P; Liu Y; Zhang B; Gu X; Wang Y; Li M; Zhao Y; Cui B
Aging (Albany NY); 2020 Oct; 12(20):20396-20412. PubMed ID: 33109776
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
[TBL] [Abstract][Full Text] [Related]
15. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
Au SL; Wong CC; Lee JM; Wong CM; Ng IO
PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer.
Bai Y; Zhang Z; Cheng L; Wang R; Chen X; Kong Y; Feng F; Ahmad N; Li L; Liu X
J Biol Chem; 2019 Jun; 294(25):9911-9923. PubMed ID: 31085587
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancer.
Shi B; Behrens C; Vaghani V; Riquelme EM; Rodriguez-Canales J; Kadara H; Lin H; Lee J; Liu H; Wistuba I; Simon G
Cancer Med; 2019 Oct; 8(14):6383-6392. PubMed ID: 31456359
[TBL] [Abstract][Full Text] [Related]
18. Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer.
Ishikawa S; Hayashi H; Kinoshita K; Abe M; Kuroki H; Tokunaga R; Tomiyasu S; Tanaka H; Sugita H; Arita T; Yagi Y; Watanabe M; Hirota M; Baba H
Int J Cancer; 2014 Dec; 135(11):2528-36. PubMed ID: 24346863
[TBL] [Abstract][Full Text] [Related]
19. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
[TBL] [Abstract][Full Text] [Related]
20. The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer.
Li X; Xing J; Wang H; Yu E
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30038060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]